Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized 5% hypertonic saline in children with chronic suppurative lung disease
NCT04765033Phase 4Completed
- Sponsor
- Universiti Malaya
- Start
- Feb 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of hypertonic saline in bronchiectasis, chronic suppurative lung disease (CSLD), sponsored by Universiti Malaya. Started Feb 2021; status: completed.
02
Drugs
hypertonic saline
03
Conditions
bronchiectasischronic suppurative lung disease (CSLD)
Beyond the preview
Go deeper on NCT04765033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04765033.